Cardiovascular Benefits of Exercise Training in Postmenopausal Hypertension.

Yi-Yuan Lin, Shin-Da Lee
Author Information
  1. Yi-Yuan Lin: Graduate Institute of Clinical Medical Science, China Medical University, Taichung 40402, Taiwan. charlet8116@gmail.com.tw. ORCID
  2. Shin-Da Lee: Department of Physical Therapy, Graduate Institute of Rehabilitation Science, China Medical University, Taichung 40402, Taiwan. shinda@mail.cmu.edu.tw. ORCID

Abstract

Exercise training is often considered the cornerstone of nonpharmacological therapy for postmenopausal hypertension while aerobic exercise is the mainstay of life style modification for antihypertension. Moderate-intensity aerobic exercise is well tolerated on most days of the week by most people with postmenopausal hypertension and is not suspected to detract from exercise adherence. That being said, moderate aerobic exercise may be superior for eliciting cardiovascular benefits in hypertensive postmenopausal women and resistance exercise may offer desirable benefits. The beneficial outcomes of exercise training for hypertensive postmenopausal women include improvements in blood pressure, autonomic tone, baroreflex sensitivity, oxidative stress, nitric oxide (NO), bioavailability, and lipid profiles, as well as cardiovascular function and cardiorespiratory fitness. This partly explains the fact that exercise training programs have a positive effect for cardiovascular disease in hypertensive postmenopausal women. This review is to collect and present the literature of exercise training in postmenopausal hypertension. Our review may provide the current understanding of beneficial effects and mechanisms of exercise intervention for prevention and treatment of stage 1 to 2 hypertensive postmenopausal women.

Keywords

References

  1. Circulation. 2003 Jan 7;107(1):e2-5 [PMID: 12515760]
  2. Hypertension. 2018 Jun;71(6):1269-1324 [PMID: 29133354]
  3. J Clin Endocrinol Metab. 2003 Jun;88(6):2404-11 [PMID: 12788835]
  4. J Clin Transl Endocrinol. 2014 Jul 11;1(3):108-114 [PMID: 29159091]
  5. Menopause. 2017 Mar;24(3):262-268 [PMID: 27779565]
  6. Mayo Clin Proc. 2009 Apr;84(4):373-83 [PMID: 19339657]
  7. PLoS One. 2014 Dec 31;9(12):e115970 [PMID: 25551214]
  8. Int J Endocrinol. 2017;2017:5465869 [PMID: 28761442]
  9. Chin J Physiol. 2016 Jun 30;59(3):165-72 [PMID: 27188469]
  10. Physiother Res Int. 2014 Jun;19(2):93-8 [PMID: 24022919]
  11. J Hum Hypertens. 1998 Sep;12(9):587-92 [PMID: 9783485]
  12. Cardiovasc Diabetol. 2017 Apr 4;16(1):44 [PMID: 28376896]
  13. Rev Bras Ginecol Obstet. 2009 May;31(5):254-61 [PMID: 19669034]
  14. Pharmacol Ther. 2010 Oct;128(1):191-227 [PMID: 20438756]
  15. Int J Cancer. 1999 May 5;81(3):339-44 [PMID: 10209946]
  16. BMC Womens Health. 2009 Jun 19;9:17 [PMID: 19545388]
  17. Med Sci Sports Exerc. 2010 Feb;42(2):288-95 [PMID: 19927030]
  18. Circulation. 2010 Sep 21;122(12):1221-38 [PMID: 20855669]
  19. J Hum Kinet. 2014 Nov 12;43:185-90 [PMID: 25713659]
  20. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):756-64 [PMID: 23652373]
  21. Menopause. 2006 Jan-Feb;13(1):87-95 [PMID: 16607103]
  22. Circulation. 1996 May 15;93(10):1928-37 [PMID: 8635273]
  23. J Appl Physiol (1985). 2011 Jul;111(1):311-20 [PMID: 21436465]
  24. Am J Physiol Regul Integr Comp Physiol. 2010 Aug;299(2):R683-93 [PMID: 20504902]
  25. Prog Cardiovasc Dis. 2011 May-Jun;53(6):404-11 [PMID: 21545926]
  26. Menopause. 2012 May;19(5):562-8 [PMID: 22157682]
  27. Braz J Med Biol Res. 2015 Jun;48(6):523-7 [PMID: 25831206]
  28. Braz J Med Biol Res. 2017 Jan 16;50(1):e5495 [PMID: 28099583]
  29. J Clin Hypertens (Greenwich). 2007 Jul;9(7):546-50 [PMID: 17617765]
  30. Int J Mol Sci. 2016 Dec 06;17(12): [PMID: 27929425]
  31. J Appl Physiol (1985). 2012 Mar;112(5):883-91 [PMID: 22207725]
  32. J Cardiovasc Risk. 2001 Oct;8(5):283-90 [PMID: 11702034]
  33. J Exerc Rehabil. 2015 Jun 30;11(3):145-50 [PMID: 26171380]
  34. Nat Commun. 2014 Aug 21;5:4708 [PMID: 25144627]
  35. Indian J Endocrinol Metab. 2018 Mar-Apr;22(2):223-228 [PMID: 29911036]
  36. J Endocrinol Invest. 2015 Jul;38(7):761-7 [PMID: 25722224]
  37. Pathophysiol Haemost Thromb. 2002 Sep-Dec;32(5-6):325-8 [PMID: 13679667]
  38. J Appl Physiol (1985). 2016 Oct 1;121(4):1032-1038 [PMID: 27339182]
  39. J Appl Physiol (1985). 2016 Aug 1;121(2):457-65 [PMID: 27339185]
  40. Sports Med. 2003;33(14):1013-35 [PMID: 14599231]
  41. Methodist Debakey Cardiovasc J. 2017 Jan-Mar;13(1):20-24 [PMID: 28413578]
  42. Menopause. 2011 Sep;18(9):980-4 [PMID: 21540753]
  43. Med J Malaysia. 2013 Dec;68(6):459-64 [PMID: 24632913]
  44. Menopause. 2012 Mar;19(3):296-301 [PMID: 22089179]

MeSH Term

Animals
Antioxidants
Apoptosis
Blood Pressure
Body Mass Index
Cardiovascular Physiological Phenomena
Exercise
Female
Heart Rate
Humans
Hypertension
Lipid Metabolism
Nitric Oxide
Oxidative Stress
Postmenopause
Resistance Training
Ventricular Remodeling

Chemicals

Antioxidants
Nitric Oxide

Word Cloud

Created with Highcharts 10.0.0exercisepostmenopausaltraininghypertensivewomenhypertensionaerobicmaycardiovascularExercisewellbenefitsbeneficialdiseasereviewoftenconsideredcornerstonenonpharmacologicaltherapymainstaylifestylemodificationantihypertensionModerate-intensitytolerateddaysweekpeoplesuspecteddetractadherencesaidmoderatesuperiorelicitingresistanceofferdesirableoutcomesincludeimprovementsbloodpressureautonomictonebaroreflexsensitivityoxidativestressnitricoxideNObioavailabilitylipidprofilesfunctioncardiorespiratoryfitnesspartlyexplainsfactprogramspositiveeffectcollectpresentliteratureprovidecurrentunderstandingeffectsmechanismsinterventionpreventiontreatmentstage12CardiovascularBenefitsTrainingPostmenopausalHypertensionapoptosiscardiacremodelingfibrosisheartphysical

Similar Articles

Cited By